Jackson, Sarah E. http://orcid.org/0000-0001-5658-6168
Beard, Emma
Michie, Susan
Shahab, Lion
Raupach, Tobias
West, Robert
Brown, Jamie
Funding for this research was provided by:
Cancer Research UK (C1417/A22962)
Article History
Received: 26 July 2018
Accepted: 18 October 2018
First Online: 14 November 2018
Ethics approval and consent to participate
: Ethical approval for the Smoking Toolkit Study was granted originally by the UCL Ethics Committee (ID 0498/001) and participants provided full informed consent. The data are not collected by UCL and are anonymised when received by UCL.
: Not applicable.
: JB and EB received unrestricted research funding from Pfizer, who manufacture smoking cessation medications. LS has received honoraria for talks, an unrestricted research grant and travel expenses to attend meetings and workshops from Pfizer and has acted as paid reviewer for grant awarding bodies and as a paid consultant for health care companies. TR has received honoraria from Pfizer, Novartis, Glaxo Smith Kline, Astra Zeneca and Roche as a speaker in activities related to continuing medical education. He has also received financial support for investigator-initiated trials from Pfizer and Johnson & Johnson. RW undertakes research and consultancy for and receives travel funds and hospitality from manufacturers of smoking cessation medications (Pfizer, GlaxoSmithKline and Johnson & Johnson). All authors declare no financial links with tobacco companies or e-cigarette manufacturers or their representatives.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.